Pacific Biosciences
PACB
#7180
Rank
HK$4.71 B
Marketcap
HK$15.10
Share price
5.77%
Change (1 day)
23.75%
Change (1 year)

P/S ratio for Pacific Biosciences (PACB)

P/S ratio as of November 2026 (TTM): 3.57

According to Pacific Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -17.1. At the end of 2026 the company had a P/S ratio of 3.22.

P/S ratio history for Pacific Biosciences from 2010 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.22-7.32%
20253.47-2.32%
20243.55-72.83%
202313.1-9.24%
202214.4-58.32%
202134.6-43.82%
202061.6610.92%
20198.66-38.76%
201814.1330.65%
20173.28-15.4%
20163.88-65.71%
201511.318.33%
20149.57-22.24%
201312.3234.69%
20123.68-18.91%
20114.53-99.1%
2010502

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Thermo Fisher Scientific
TMO
5.37 50.62%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
6.42 79.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
6.86 92.38%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
4.31 20.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
0.0312-99.13%๐Ÿ‡บ๐Ÿ‡ธ USA